Skip Navigation

Using Microbiome to Predict Durvalumab Toxicity in Post-CCRT NSCLC Patients MicroDurva

Brief Summary

Type:
Lung Cancers

Study Type:
Basic Science

Phase:
IV

ClinicalTrials.gov Identifier:
NCT04680377

Study #:
STUDY00146019

Start Date:
Jan 27, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04680377

View Complete Trial Details & Eligibility at ClinicalTrials.gov